Medical foods for Alzheimer's disease

Drugs and Aging

Volumn 28, Issue 6, 2011, Pages 421-428

  Shah, Raj C ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

AC 1202; Alzheimers disease; Dementia; Research and development

Indexed keywords

MEDIUM CHAIN TRIACYLGLYCEROL;

ALZHEIMER DISEASE; ARTICLE; CLINICAL TRIAL (TOPIC); DIET SUPPLEMENTATION; EARLY DIAGNOSIS; ENTERIC FEEDING; FEEDING BEHAVIOR; FOOD AND DRUG ADMINISTRATION; FOOD COMPOSITION; FOOD SAFETY; GASTROINTESTINAL SYMPTOM; GENERAL CONDITION IMPROVEMENT; HUMAN; KETOGENESIS; MACRONUTRIENT; MEDICAL FOOD; MEDICAL SERVICE; MEDLINE; METABOLISM; NONHUMAN; NUTRITIONAL REQUIREMENT; NUTRITIONAL VALUE; PRIORITY JOURNAL; SYNAPTIC EFFICACY; TREATMENT RESPONSE; VERBAL MEMORY;

ALZHEIMER DISEASE; ANIMALS; CLINICAL TRIALS AS TOPIC; FOOD; HUMANS;

EID: 79958248678     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.2165/11587380-000000000-00000     Document Type: Article

References (31)

1. Alzheimer's Disease International. World Alzheimer report London: Alzheimer's Disease International, 2009
2. Alzheimer's Disease International. World Alzheimer report London: Alzheimer's Disease International, 2010
3. Hansen RA, Gartlehner G, Webb AP, et al. Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis. Clin Interv Aging 2008; 3 (2): 211-25 (Pubitemid 352037861)
4. Birks J. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev 2006 Jan 25; (1): CD005593
5. McShane R, Areosa Sastre A, Minakaran N. Memantine for dementia. Cochrane Database Syst Rev 2006 Apr 19; (2): CD003154
6. Silverberg GD, Levinthal E, Sullivan EV, et al. Assessment of low-flow CSF drainage as a treatment for AD: results of a randomized pilot study. Neurology 2002; 59 (8); 1139-45 (Pubitemid 35192382)
7. Mangialasche F, Solomon A, Winblad B, et al. Alzheimer's disease: clinical trials and drug development. Lancet Neurol 2010 Jul; 9 (7): 702-16
8. Mandel RJ. Cere-110, an adeno-associated virus-based gene delivery vector expressing human nerve growth factor for the treatment of Alzheimer's disease. Curr Opin Mol Ther 2010 Apr; 12 (2): 240-7
9. Kelly BJ, Knopman DS. Alternative medicine and Alzheimer disease. Neurologist 2008 Sep; 14 (5): 299-306
10. Henderson ST, Vogel JL, Barr LJ, et al. Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial. Nutr Metab (Lond) 2009; 6: 31
11. US Food and Drug Administration. What is the difference between a dietary supplement and a conventional food? [online]. Available from URL: http://www.fda.gov/About FDA/Transparency/Basics/ucm194357.htm. [Accessed 2010 Sep 27]
12. US Food and Drug Administration. Overview of dietary supplements [online]. Available from URL: http://www.fda.gov/Food/DietarySupplements/ ConsumerInformation/ucm110417.htm [Accessed 2010 Sep 27]
13. US Food and Drug Administration. Claims that can be made for conventional foods and dietary supplements [online]. Available from URL: http://www.fda.gov/Food/LabelingNutrition/LabelClaims/ucm111447.htm [Accessed 2010 Sep 27]
14. US Food and Drug Administration. Medical foods: overview [online]. Available from URL: http://www.fda.gov/Food/FoodSafety/Product- SpecificInformation/Medical Foods/default.htm [Accessed 2010 Sep 27]
15. US Food and Drug Administration. Guidance for industry: frequently asked questions about medical foods May 1997 - revised May 2007 [online]. Available from URL: http://www.fda.gov/Food/GuidanceComplianceRegulatoryInfor mation/GuidanceDocuments/MedicalFoods/UCM054048 [Accessed 2010 Sep 27]
16. The Commission of the European Communities. Commission Directive 1999/21/EC of 25 March 1999 on dietary foods for special medical purposes. Official Journal L 091, 07/04/1999 P. 0029-0036 [online]. Available from URL: http://eur-lex.europa.eu/LexUriServ/LexUriServ. döuri=CELEX:31999L0021:EN: HTML [Accessed 2011 Jan 25]
17. The Commission of the European Communities. Commission Regulation (EC) No 953/2009 of 13 October 2009 on substances that may be added for specific nutritional purposes in foods for particular nutritional uses. Official Journal L 296, 14/10/2009 P. 0009-0019 [online]. Available from URL: http://eur-lex.europa.eu/LexUriServ/LexUri Serv.döuri=OJ:L:2009:269:0009: 01:EN:HTML [Accessed 2011 Jan 25]
18. Sampson EL, Candy B, Jones L. Enteral tube feeding for older people with advanced dementia. Cochrane Database Syst Rev 2009 Apr 15; (2): CD007209
19. Wang PN, Yang CL, Lin KN, et al. Weight loss, nutritional status and physical activity in patients with Alzheimer's disease: a controlled study. J Neurol 2004; 251: 314-20
20. Cronin-Stubbs D, Beckett LA, Scherr PA, et al. Weight loss in people with Alzheimer's disease: a prospective population based analysis. BMJ 1997; 314: 178-9 (Pubitemid 27037869)
21. Riviere S, Gillette-Guyonnet S, Voisin T, et al. A nutritional education program could prevent weight loss and slow cognitive decline in Alzheimer's disease. J Nutr Health Aging 2001; 5: 295-1259
22. Gillette-Guyonnet S, Nourhashemi F, Andrieu S, et al. Weight loss in Alzheimer disease. Am J Clin Nutr 2000; 71: S637-42
23. Tamura BK, Masaki KH, Blanchette P. Weight loss in patients with Alzheimer's disease. J Nutr Elder 2007; 26: 21-38 (Pubitemid 351664738)
24. Ferreira IL, Resende R, Ferreiro E, et al. Multiple defects in energy metabolism in Alzheimer's disease. Curr Drug Targets 2010; 20: 1193-206
25. Kamphuis PJ, Scheltens P. Can nutrients prevent or delay onset of Alzheimer's disease? J Alzheimers Dis 2010; 20: 765-75
26. Scheltens P, Kamphuis PJ, Verhey FR, et al. Efficacy of a medical food in mild Alzheimer's disease: a randomized, controlled trial. Alzheimers Dement 2010; 6: 1-10.e1
27. Grill J. A positron emission tomography (PET) study evaluating brain metabolism of a medical food in Alzheimer's disease (AD) [ClinicialTrials.gov identifier NCT01122329]. US National Institutes of Health, ClinicalTrials.gov [online]. Available from URL: http://www.clinicaltrials.gov [Accessed 2010 Oct 2]
28. Danone Research BV. A randomized controlled trial to assess the efficacy of a food in patients with mild to moderate Alzheimer's disease using Alzheimer's disease medication (TrialRegister.nl identifier NTR1683) [online]. Available from URL: https://www.trialregister.nl [Accessed 2010 Oct 2]
29. Newsome D. Copperproof-2: prospective, randomized, double-blind placebo-controlled clinical trial comparing the effects of a novel once-daily oral zinc cysteine preparation on zinc and copper parameters in mild cognitive impairment and Alzheimer's disease [ClinicialTrials.gov identifier NCT01099332]. US National Institutes of Health, ClinicalTrials.gov [online]. Available from URL: http://www.clinicaltrials.gov [Accessed 2011 Jan 25]
30. Parachikova A, Green KN, Hendrix C, et al. Formulation of a medical food cocktail for Alzheimer's disease: beneficial effects on cognition and neuropathology in a mouse model of the disease. PLoS ONE 2010; 5 (11): e14015
31. Alzheimer's Association. Medical foods [online]. Available from URL: http://www.alz.org/national/documents/state mentsmedicalfoods.pdf [Accessed 2010 Sep 30]